Skip navigational links

Life Sciences Newsletter, March 2010


Volume 4, Issue 1
Editor: Karen Gibbs, Esquire

  • U.S. Government Cracks Down on Pharmaceutical and Medical Device Companies and Research Institutions for Export Control and FCPA Violations
    Doreen Edelman, Esquire
    Abbey Baker
  • Toward a Global Biosimilar Strategy: Latest Developments in U.S. and European Regulation
    Keith Harrison, Esquire
  • Indecent Pricing Exposure: State Healthcare Laws Mandating Publication of Price Discounts Could Harm Consumers
    Jim Rill, Esquire
    Mike Cowie, Esquire
  • Seeking Counsel: No Fault? Not Quite
    Arnie Friede, Esquire
  • Brave New FDA: When an Unstoppable Force Meets a (Not) Immovable Object
    Melissa Gilmore, Esquire
© 2018 American Health Lawyers Association. All rights reserved. 1620 Eye Street NW, 6th Floor, Washington, DC 20006-4010 P. 202-833-1100 F. 202-833-1105